Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers-Reference-Cited by-同舟云学术

Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers

Published:2013-05-25 Issue:9 Volume:133 Page:2234-2244
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kharma Budiman¹,Baba Tsukasa¹,Mandai Masaki¹,Matsumura Noriomi¹,Murphy Susan K.²,Kang Hyun Sook¹,Yamanoi Koji¹,Hamanishi Junzo¹,Yamaguchi Ken¹,Yoshioka Yumiko¹,Konishi Ikuo¹

Affiliation:

1. Department of Gynecology and Obstetrics; Kyoto University Graduate School of Medicine; Kyoto; Japan

2. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology; Duke University Medical Center; Durham; NC

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Endometrial cancer;Sorosky;Obstet Gynecol,2008

2. Treatment options for advanced endometrial carcinoma;Dizon;Gynecol Oncol,2010

3. Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy;Huh;Gynecol Oncol,2003

4. Adjuvant therapy for endometrial cancer: “Sandwich therapy” of carboplatin and paclitaxel with radiation therapy. The Women and Infants' Hospital experience and review of the literature;Dizon;Cancer Ther,2007

5. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study;Fleming;J Clin Oncol,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in research on autophagy mechanisms in resistance to endometrial cancer treatment;Frontiers in Oncology;2024-03-27

2. Immunotherapy for Gynecologic Cancer;Handbook of Cancer and Immunology;2023

3. L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma;International Journal of Cancer;2022-05-10

4. Immunosuppressive tumor microenvironment in uterine serous carcinoma via CCL7 signal with myeloid-derived suppressor cells;Carcinogenesis;2022-03-30

5. Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines;Molecular Oncology;2021-01-04